2/5/2014 7:57:04 AM
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer and other hormonally driven cancers, today announced that Jodie Morrison, president and chief executive officer, will present an overview of the company and the recently presented interim Phase 2 data on its lead prostate cancer drug candidate galeterone at the Leerink Global Healthcare Conference on Wednesday, February 12, 2014 at 3:05 p.m. (ET) in New York City.
Help employers find you! Check out all the jobs and post your resume.
comments powered by